S. 2512 — Reported in Senate

II Calendar No. 389 114th CONGRESS 2d Session S. 2512 IN THE SENATE OF THE UNITED STATES February 8, 2016Mr. Franken (for himself, Mr. Nelson, Mr. Isakson, Mr. Brown, Mr. Menendez, Mr. Kirk, Mr. Casey, Mr. Portman, Mr. Murphy, Ms. Klobuchar, Mrs. Murray, and Mr. Alexander) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions March 15, 2016Reported by Mr. Alexander, with an amendmentStrike out all after the enacting clause and insert the part printed in italic A BILL To expand the tropical disease product priority review voucher program to encourage treatments for Zika virus. 1. Short title This Act may be cited as the Adding Zika Virus to the FDA Priority Review Voucher Program Act. 2. Expanding tropical disease product priority review voucher program to encourage treatments for Zika virus Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n) is amended— (1) by redesignating subparagraph (R) as subparagraph (S); and (2) by inserting after subparagraph (Q) the following: (R) Zika virus. . 1. Short title This Act may be cited as the Adding Zika Virus to the FDA Priority Review Voucher Program Act. 2. Expanding tropical disease product priority review voucher program to encourage treatments for Zika Virus Disease Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n(a)(3)) is amended— (1) by redesignating subparagraph (R) as subparagraph (S); (2) in subparagraph (Q), by striking Filoviruses and inserting Filovirus Diseases; and (3) by inserting after subparagraph (Q) the following: (R) Zika Virus Disease. . March 15, 2016Reported with an amendment